This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denley, A.
Right arrow Articles by Roberts, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denley, A.
Right arrow Articles by Roberts, C. T., Jr.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, May 2007, p. 3569-3577, Vol. 27, No. 10
0270-7306/07/$08.00+0     doi:10.1128/MCB.01447-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Differential Activation of Insulin Receptor Substrates 1 and 2 by Insulin-Like Growth Factor-Activated Insulin Receptors{triangledown}

Adam Denley ,1,2,{dagger},{ddagger} Julie M. Carroll,1,{ddagger} Gemma V. Brierley,3 Leah Cosgrove,3 John Wallace,2 Briony Forbes,2 and Charles T. Roberts Jr.1*

Department of Pediatrics, Oregon Health and Science University, Portland, Oregon 97239,1 School of Molecular and Biomedical Science, University of Adelaide, Adelaide 5005, Australia,2 CSIRO Division of Molecular and Health Technologies, Adelaide 5000, Australia3

Received 4 August 2006/ Returned for modification 13 October 2006/ Accepted 13 February 2007

The insulin-like growth factors (insulin-like growth factor I [IGF-I] and IGF-II) exert important effects on growth, development, and differentiation through the IGF-I receptor (IGF-IR) transmembrane tyrosine kinase. The insulin receptor (IR) is structurally related to the IGF-IR, and at high concentrations, the IGFs can also activate the IR, in spite of their generally low affinity for the latter. Two mechanisms that facilitate cross talk between the IGF ligands and the IR at physiological concentrations have been described. The first of these is the existence of an alternatively spliced IR variant that exhibits high affinity for IGF-II as well as for insulin. A second phenomenon is the ability of hybrid receptors comprised of IGF-IR and IR hemireceptors to bind IGFs, but not insulin. To date, however, direct activation of an IR holoreceptor by IGF-I at physiological levels has not been demonstrated. We have now found that IGF-I can function through both splice variants of the IR, in spite of low affinity, to specifically activate IRS-2 to levels similar to those seen with equivalent concentrations of insulin or IGF-II. The specific activation of IRS-2 by IGF-I through the IR does not result in activation of the extracellular signal-regulated kinase pathway but does induce delayed low-level activation of the phosphatidylinositol 3-kinase pathway and biological effects such as enhanced cell viability and protection from apoptosis. These findings suggest that IGF-I can function directly through the IR and that the observed effects of IGF-I on insulin sensitivity may be the result of direct facilitation of insulin action by IGF-I costimulation of the IR in insulin target tissues.

* Corresponding author. Present address: Oregon National Primate Research Center, L584, 505 NW 185th Ave., Beaverton, OR 97006-3448. Phone: (503) 690-5259. Fax: (503) 690-5384. E-mail: robertsc{at}ohsu.edu

{triangledown} Published ahead of print on 26 February 2007.

{dagger} Present address: Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037.

{ddagger} These authors contributed equally to this work.

Molecular and Cellular Biology, May 2007, p. 3569-3577, Vol. 27, No. 10
0270-7306/07/$08.00+0     doi:10.1128/MCB.01447-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., Vigneri, R. (2009). Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease. Endocr. Rev. 30: 586-623 [Abstract] [Full Text]  
  • Kim, W.-Y., Jin, Q., Oh, S.-H., Kim, E. S., Yang, Y. J., Lee, D. H., Feng, L., Behrens, C., Prudkin, L., Miller, Y. E., Lee, J. J., Lippman, S. M., Hong, W. K., Wistuba, I. I., Lee, H.-Y. (2009). Elevated Epithelial Insulin-like Growth Factor Expression Is a Risk Factor for Lung Cancer Development. Cancer Res. 69: 7439-7448 [Abstract] [Full Text]  
  • Li, G., Barrett, E. J., Ko, S.-H., Cao, W., Liu, Z. (2009). Insulin and Insulin-Like Growth Factor-I Receptors Differentially Mediate Insulin-Stimulated Adhesion Molecule Production by Endothelial Cells. Endocrinology 150: 3475-3482 [Abstract] [Full Text]  
  • Sacco, A., Morcavallo, A., Pandini, G., Vigneri, R., Belfiore, A. (2009). Differential Signaling Activation by Insulin and Insulin-Like Growth Factors I and II upon Binding to Insulin Receptor Isoform A. Endocrinology 150: 3594-3602 [Abstract] [Full Text]  
  • Sabbatini, P., Rowand, J. L., Groy, A., Korenchuk, S., Liu, Q., Atkins, C., Dumble, M., Yang, J., Anderson, K., Wilson, B. J., Emmitte, K. A., Rabindran, S. K., Kumar, R. (2009). Antitumor Activity of GSK1904529A, a Small-molecule Inhibitor of the Insulin-like Growth Factor-I Receptor Tyrosine Kinase. Clin. Cancer Res. 15: 3058-3067 [Abstract] [Full Text]  
  • Ganeff, C., Chatel, G., Munaut, C., Frankenne, F., Foidart, J.-M., Winkler, R. (2009). The IGF system in in-vitro human decidualization. Mol Hum Reprod 15: 27-38 [Abstract] [Full Text]  
  • Torres-Aleman, I. (2008). Mouse Models of Alzheimer's Dementia: Current Concepts and New Trends. Endocrinology 149: 5952-5957 [Abstract] [Full Text]  
  • Lotton, C., Rodrigue, D., Elie, C., Rothenbuhler, A., Lahlou, N., Le Stunff, C., Bougneres, P. (2008). Akt Phosphorylation in Lymphocytes Provides an Index of in Vitro Insulin-Like Growth Factor I Sensitivity Associated with Growth Hormone-Induced Growth. J. Clin. Endocrinol. Metab. 93: 1458-1463 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»